Publications by authors named "Suba Krishnan"

Claim this Profile
T
Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial.
David A Reardon, Tae Min Kim, Jean-Sebastien Frenel, Matteo Simonelli, Juanita Lopez, Suba Krishnan

Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies.
Sarina A Piha-Paul, Do-Youn Oh, Makoto Ueno, David Malka, Hyun Cheol Chung, Suba Krishnan

Int J Cancer· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.
Hyun Cheol Chung, Sarina A Piha-Paul, Jose Lopez-Martin, Jan H M Schellens, Steven Kao, Suba Krishnan

J Thorac Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study.
Margaret K Callahan, Harriet Kluger, Michael A Postow, Neil H Segal, Alexander Lesokhin, Suba Krishnan

J Clin Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody.
Neil H Segal, Theodore F Logan, F Stephen Hodi, David McDermott, Ignacio Melero, Suba Krishnan

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.
Padmanee Sharma, Margitta Retz, Arlene Siefker-Radtke, Ari Baron, Andrea Necchi, Suba Krishnan

Lancet Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.
B N Yamaja Setty, Nigel S Key, A Koneti Rao, Suhita Gayen-Betal, Suba Krishnan

Br J Haematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease.
Charles T Quinn, Marie J Stuart, Karen Kesler, Kenneth I Ataga, Winfred C Wang, Suba Krishnan

Br J Haematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.
Suba Krishnan, Yamaja Setty, Suhita G Betal, Vaidyula Vijender, Koneti Rao

Br J Haematol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased von Willebrand factor antigen and high molecular weight multimers in sickle cell disease associated with nocturnal hypoxemia.
Suba Krishnan, Jamie Siegel, Gene Pullen, Megan Hevelow, Carlton Dampier

Thromb Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annexin II-mediated plasmin generation activates TGF-beta3 during epithelial-mesenchymal transformation in the developing avian heart.
Suba Krishnan, Arunkumar B Deora, Justin P Annes, Jerelyn Osoria, Daniel B Rifkin

Dev Biol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis